Introduction
============

Early-life adversity (ELA) is defined as traumatic experiences during childhood encompassing maltreatment, accidents, death of a close relative, and disaster, any of which could have an influence not only in childhood but also in later life in the form of difficulties such as posttraumatic stress disorder (PTSD) or irritable bowel syndrome.[@b1-jpr-10-427],[@b2-jpr-10-427] Previous studies have also described the relationship between ELA events and chronic pain (e.g., low back pain or fibromyalgia), but most of these studies were small-scale or targeted to North American, European, Oceanian populations,[@b3-jpr-10-427]--[@b7-jpr-10-427] and once targeted to Japanese population.[@b8-jpr-10-427]

This study focuses on the effects of ELA as a broader concept in relation to chronic pain. We used a question about adverse life events in general, rather than specific adversities.

Various sex or gender differences in tolerance for stressful life events have been documented. For example, a meta-analytic review revealed that women reported more symptoms of depression and anxiety than did men, but that the sex difference in psychological symptoms accounted for only about 4% of the variance in sex differences in reports of stress.[@b9-jpr-10-427] Sex or gender differences as they relate to chronic pain have been discussed for decades. The prevalence of chronic pain among women is higher than that among men,[@b10-jpr-10-427],[@b11-jpr-10-427] and somatic symptoms have been reported by women than by men.[@b12-jpr-10-427],[@b13-jpr-10-427]

We hypothesized that ELA would have long-term adverse impact, which manifested as chronic pain on more women than men, so we investigated the sex-specific association between ELA and the prevalence of chronic pain, chronic multisite pain, and somatizing tendency complicated by chronic pain in a large population-based study of Japanese men and women aged 20--79 years.

Methods
=======

Ethical provisions
------------------

All procedures followed were in accordance with the ethical standards of the Helsinki Declaration of 1975 as revised in 2000. The institutional review boards of Keio University and of the Japan Labour Health and Welfare Organization approved this study. All participants had given their written informed consent before responding to the questionnaire. A credit point for Internet shopping was given as an incentive to the respondents.

Study population
----------------

The Pain Associated Cross-Sectional Epidemiological (PACE) study was a web-based survey designed to evaluate pain in a large Japanese population using a self-reported questionnaire. The PACE survey was conducted from 10 to 18 January 2009. The data set was the same as in previous PACE studies, profiles of which have been reported elsewhere;[@b14-jpr-10-427],[@b15-jpr-10-427] however, the aim of this study was completely different from that of previous studies. [Figure 1](#f1-jpr-10-427){ref-type="fig"} shows the sampling procedure that culminated in the sample analyzed in the present study. A total of 20,044 respondents (9,746 men and 10,298 women) aged 20--79 years and matching the Japanese demographic composition in 2007 (Japanese Ministry of Internal Affairs and Communications, 2007) were recruited by e-mail from 1,477,585 candidates who registered with an Internet survey company (Rakuten Research, Inc., Tokyo, Japan). Computer-generated invitational e-mails were sent with a link to the first questionnaire until the targeted sample number was achieved. Incomplete questionnaires were rejected automatically, so the response rate was not calculated. The first questionnaire included items on age, sex, and pain, and was completed by 20,044 respondents. Subsequently, detailed questionnaires about lifestyle and psychosocial factors were sent to 5,000 of these respondents. Half (2,500) were chosen from those who had reported pain on the first questionnaire; the other half had reported being pain-free. The profile of these 5,000 respondents was consistent with the Japanese demographic composition for sex and age in 2007.[@b16-jpr-10-427] A total of 5,000 participants responded to the second questionnaire. Of these, we drew the data on 4,229 individuals (1,729 with chronic pain and 2,500 without pain) in the analyses. Moreover, the respondents with chronic pain were included in some additional analyses.

Definitions and measures
------------------------

### Chronic pain

The first questionnaire included items on pain such as the pain sites, pain intensity at each site, the site of dominant pain, and the duration of dominant pain. Pain intensities were scored on an 11-point Numerical Rating Scale (NRS; 0=no pain, 10=worst pain imaginable). In accord with the definition of chronic pain from the International Association for the Study of Pain, participants reported persistent pain over 3 months.[@b17-jpr-10-427]

### Early-life adversity

We used a simple yes/no question to detect ELA, "Did you have any mentally shocking events (e.g., accidents experienced by you or close relatives, death of close relatives or friends, disaster, injury from violence) when you were 14 years old or younger?".

### Multisite pain

The questionnaire included a picture of a human form with its body parts numbered from 1 to 21, and respondents entered the number(s) that corresponded to their pain site(s). A count of pain sites is a simple and useful measure for the severity of chronic pain, and chronic multisite pain is a strong predictor of future disability.[@b18-jpr-10-427] We defined more than three pain sites as multisite pain in the current study.

### Somatizing tendency

Somatic symptom disorder involves having physical symptoms such as fatigue or dizziness caused by major emotional distress and problems functioning.[@b19-jpr-10-427] The disorder decreases its sufferers' quality of life. The Brief Symptom Inventory (BSI) is a self-reported measure of somatic symptoms, in which respondents answer on a 5-point Likert-type scale, ranging from 0 (not at all) to 4 (extremely), regarding each of seven symptoms during the past 7 days: faintness or dizziness, pain in the heart or chest, nausea or upset stomach, trouble catching one's breath, numbness or tingling in parts of one's body, feeling weak in parts of one's body, and hot or cold spells.[@b20-jpr-10-427] Endorsing a response of 2, 3, or 4 was considered presence of the symptom. The number of symptoms with this level of response was counted; the totals ranged from zero to seven symptoms. We defined respondents with ≥3 symptoms, the highest tertile of the symptom count in our data, as existence of the somatizing tendency.

### Mental status

We used the Mental Health Inventory (MHI-5), which is identical to the 36-item Short Form Health Survey (SF-36) "Mental Health" domain, to measure mental status.[@b21-jpr-10-427],[@b22-jpr-10-427] The MHI-5 includes the following five questions: "How much of the time during the last month have you: 1) been a very nervous person?, 2) felt downhearted and blue?, 3) felt calm and peaceful?, 4) felt so down in the dumps that nothing could cheer you up?, and 5) been a happy person?". The respondents choose a number from 1 (all of the time) to 6 (none of the time).[@b21-jpr-10-427] The total score, which ranges from 5 to 30 points, is converted to a 100-point scale.[@b21-jpr-10-427] A previous Japanese study validated the cut point of \<52 on the MHI-5 as screening for severe depressive symptoms.[@b21-jpr-10-427]

Statistical analysis
--------------------

A Student's *t*-test was conducted to test for differences in age-adjusted mean values and proportions of risk factors for chronic pain. A chi-square test was performed to test for sex differences in the proportion of ELA.

Three outcomes were measured in the current study, 1) chronic pain prevalence among all respondents, 2) chronic multisite pain (≥3 sites) prevalence, and 3) multiple somatic symptoms (≥3 symptoms) among respondents with chronic pain, as these variables related to the presence or absence of ELA.

Multivariable-adjusted odds ratios (ORs) with 95% confidence intervals (CIs) were calculated using a logistic regression model to compare respondents with and without ELA.

*p*-Values \<0.05 for two-tailed tests were considered statistically significant. All statistical analyses were performed using SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA).

Confounding variables
=====================

We adjusted all analyses for the following confounding variables: age, smoking status (never, ex-smoker, or current smoker), have an exercise routine (exercise longer than 30 minutes more than twice a week; yes or no), sleep time (hours/day), body mass index (kg/m^2^, categorized in quintiles), household expenditure (JPY/month), and the full distribution of scores on the MHI-5.

We further adjusted for pain intensity (the NRS that ranged from 0 to 10, i.e., 0=no pain, 10=worst pain imaginable) when we analyzed the data for respondents with chronic pain.

Results
=======

[Table 1](#t1-jpr-10-427){ref-type="table"} shows age-adjusted mean values of chronic pain risk factors according to the existence of ELA. Men with ELA were older (52.0 vs. 47.9 years), were more likely to have an exercise routine (45.9% vs. 33.7%), had a higher prevalence of body mass index ≥25 (31.8% vs. 24.8%), had higher household expenditures (380,000 vs. 293,000 JPY/month), had a higher proportion of severe depressive symptoms (27.3% vs. 19.5%), and had a higher prevalence of chronic pain (53.7% vs. 38.0%) compared with those who did not report ELA. Women with ELA had a higher prevalence of body mass index ≥25 (20.7% vs. 11.9%), severe depressive symptoms (38.5% vs. 20.2%), chronic pain (55.0% vs. 39.7%), and severe intensity of pain (6.5% vs. 6.1%) compared with those without it.

The prevalence of ELA was higher in women than in men (14.2% of women, 11.8% of men; *p*\<0.01).

Multivariable-adjusted ORs of chronic pain prevalence of respondents with ELA are shown in [Table 2](#t2-jpr-10-427){ref-type="table"}. Multivariable-adjusted OR of chronic pain prevalence of men with ELA was 1.62 (1.22--2.15, *p*\<0.01), and that of women with ELA was 1.47 (1.13--1.90, *p*\<0.01).

[Table 3](#t3-jpr-10-427){ref-type="table"} indicates multivariable-adjusted ORs of multisite pain (≥3 sites) among chronic pain sufferers with ELA. ELA was associated with higher risk for multisite pain among female chronic pain patients: multivariable-adjusted OR was 1.78 (1.22--2.60, *p*\<0.05). However, there was no such association for men: multivariable-adjusted OR was 1.38 (0.88--2.16, *p*=0.26).

In [Table 4](#t4-jpr-10-427){ref-type="table"}, ORs of multiple somatic symptoms (≥3 symptoms) for ELA among chronic pain sufferers are shown. The multivariable-adjusted OR of multiple somatic symptoms was 1.89 (1.27--2.83, *p*\<0.01) for women with ELA. For men, ELA was not associated with somatic symptoms.

Discussion
==========

The aim of this study was to examine the sex-specific impact of ELA on chronic pain, chronic multisite pain, and somatizing tendency with chronic pain. We hypothesized that ELA would have long-term adverse impact, which manifested as chronic pain on more women than men. The association of ELA with chronic multisite pain and with somatizing tendency among chronic pain sufferers supported our hypothesis. Although the significant associations were observed in women only, there was no sex difference in the association of ELA with the prevalence of chronic pain. Data from the Adverse Childhood Experience (ACE) study, which included 17,337 adults in the USA, also showed that ELA was associated with the prevalence of headache and with more frequent headaches in women than in men.[@b23-jpr-10-427]

ELA may reduce the volume of the hippocampus and prefrontal cortex; this reduction has been linked to major depression and to trait anxiety in adulthood, and predicts sensitivity to future stress events.[@b24-jpr-10-427],[@b25-jpr-10-427] A magnetic resonance imaging study showed that 38 patients with chronic back pain and 30 patients with complex regional pain syndrome had a significantly smaller volume of bilateral hippocampal tissue than those of 50 healthy volunteers, whereas 20 patients with osteoarthritis did not.[@b26-jpr-10-427] Additionally, mice with neuropathic pain, in comparison with sham mice, showed more cellular and molecular changes linked to reduction of hippocampal function,[@b26-jpr-10-427] so reduction in the volume of the hippocampus due to ELA may actually cause chronic pain.

Moreover, sex differences in central sensitization could support our results. Central sensitization is the phenomenon in which nociceptive pain input from the peripheral nervous system triggers a prolonged but reversible synaptic change of pain pathways in the central nervous system.[@b27-jpr-10-427] Central sensitization contributes to the development of persistent pain hypersensitivity, spreads pain sensitivity across peripheral nerve territories without inflammation,[@b27-jpr-10-427] and amplifies pain from rheumatoid arthritis, osteoarthritis, fibromyalgia, and headache, as well as neuropathic pain, complex regional pain syndrome, and postsurgical pain.[@b27-jpr-10-427] Sex differences in enhanced pain sensitivity among patients with symptomatic knee osteoarthritis have been reported.[@b28-jpr-10-427]

In a psychological approach to chronic pain patients, especially women complaining of multisite pain or exhibiting somatizing tendencies, an intervention that addresses ELA should be considered.

Limitations
===========

There were some limitations in this study. First, recall bias could exist because the current study was a cross-sectional design. The fact that people with persistent chronic pain are more likely to recall their ELA has been documented elsewhere.[@b29-jpr-10-427] Second, we used a simple and unvalidated question on ELA. A previous study of ELA among adolescents used a semi-structured interview that had good inter-rater reliability, and that study reported an association between ELA and depression.[@b30-jpr-10-427] Like that study, the current investigation concluded that respondents with ELA showed a higher prevalence of depressive syndrome than did those without it. We believe that our single item on ELA was an appropriate proxy for the validated questionnaire. Third, the respondents may not be truly representative of the general population in Japan. The sampling issues with web-based surveys have been described previously.[@b31-jpr-10-427] Elderly people often have difficulty participating in such surveys. Moreover, the decision to respond to the survey may constitute selection bias, that is, the respondents who were suffering from chronic pain may have been particularly interested in pain research.

Conclusion
==========

ELA was associated with a higher prevalence of chronic pain in both sexes, and with chronic multisite pain and somatizing tendency among women with chronic pain in the Japanese general population.
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###### 

Age-adjusted mean values and proportions of chronic pain risk factors

  Chronic pain risk factors                                                             Early-life adversity (−)   Early-life adversity (+)
  ------------------------------------------------------------------------------------- -------------------------- -------------------------------------------------------
  **Men**                                                                                                          
  n=2,050                                                                               1,808                      242
  Age, years, mean (SE)                                                                 47.9 (0.4)                 52.0 (1.0)[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Current smoker, %                                                                     27.8                       28.1
  Have an exercise habit, %                                                             33.7                       45.9[\*\*](#tfn3-jpr-10-427){ref-type="table-fn"}
  Sleep time \<5 hours, %                                                               3.4                        5.0
  Body mass index ≥25, %                                                                24.8                       31.8[\*\*\*](#tfn4-jpr-10-427){ref-type="table-fn"}
  Household expenditure ([\*](#tfn2-jpr-10-427){ref-type="table-fn"}10,000 JPY/month)   29.3                       38.0[\*\*\*](#tfn4-jpr-10-427){ref-type="table-fn"}
  Severe depressive symptoms, %                                                         19.5                       27.3[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Chronic pain, % (no. of respondents with chronic pain=817)                            38.0                       53.7[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Intensity of pain among respondents with chronic pain (0--10 scale)                   5.7                        5.7
  **Women**                                                                                                        
  n=2,179                                                                               1,870                      309
  Age, years, mean (SE)                                                                 48.8 (0.4)                 49.0 (0.9)
  Current smoker, %                                                                     14.9                       18.4
  Have an exercise habit, %                                                             29.0                       33.3
  Sleep time \<5 hours, %                                                               2.5                        3.6
  Body mass index ≥25, %                                                                11.9                       20.7[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Household expenditure ([\*](#tfn2-jpr-10-427){ref-type="table-fn"}10,000 JPY/month)   27.1                       25.5
  Severe depressive symptoms, %                                                         20.2                       38.5[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Chronic pain, % (no. of respondents with chronic pain=912)                            39.7                       55.0[\*](#tfn2-jpr-10-427){ref-type="table-fn"}
  Intensity of pain among respondents with chronic pain (0--10 scale)                   6.1                        6.5[\*\*\*](#tfn4-jpr-10-427){ref-type="table-fn"}

**Notes:** Test for significance difference from the category of no early-life adversity:

*p*\<0.001,

*p*\<0.01,

*p*\<0.05.

**Abbreviation:** SE, standard error.

###### 

ORs and 95% CIs of chronic pain prevalence of respondents with early-life adversity

                                            Early-life adversity (−)   Early-life adversity (+)
  ----------------------------------------- -------------------------- ----------------------------------------------------------------
                                                                       
  **Men**                                                              
  Number of respondents at risk             2,172                      294
  Number of respondents with chronic pain   687                        130
  Age-adjusted OR (95% CI)                  1.00                       1.86 (1.42--2.43)[\*](#tfn7-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)        1.00                       1.62 (1.22--2.15)[\*\*](#tfn8-jpr-10-427){ref-type="table-fn"}
  **Women**                                                            
  Number of respondents at risk             2,178                      356
  Number of respondents with chronic pain   742                        170
  Age-adjusted OR (95% CI)                  1.00                       1.86 (1.46--2.37)[\*](#tfn7-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)        1.00                       1.47 (1.13--1.90)[\*\*](#tfn8-jpr-10-427){ref-type="table-fn"}

**Notes:** ORs are adjusted for age, smoking status, exercise routine, sleep time, body mass index, personal consumption expenditure, and the full distribution of scores on the Mental Health Inventory-5. Test for significant difference from the category of no early-life adversity:

*p*\<0.001,

*p*\<0.01.

**Abbreviations:** CI, confidence interval; OR, odds ratio.

###### 

ORs and 95% CIs for multisite pain in chronic pain sufferers with early-life adversity

                                                              Early-life adversity (−)   Early-life adversity (+)
  ----------------------------------------------------------- -------------------------- -------------------------------------------------------------------
                                                                                         
  **Men**                                                                                
  Number of chronic pain sufferers                            687                        130
  Number of chronic pain sufferers with multisite pain (≥3)   283                        59
  Age-adjusted OR (95% CI)                                    1.00                       1.57 (1.06--2.34)[\*\*\*](#tfn13-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)                          1.00                       1.38 (0.88--2.16)
  **Women**                                                                              
  Number of chronic pain sufferers                            742                        170
  Number of chronic pain sufferers with multisite pain (≥3)   379                        117
  Age-adjusted OR (95% CI)                                    1.00                       2.27 (1.62--3.18)[\*](#tfn11-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)                          1.00                       1.78 (1.22--2.60)[\*\*](#tfn12-jpr-10-427){ref-type="table-fn"}

**Notes:** Adjusted for age, smoking status, exercise routine, sleep time, body mass index, household expenditure, the full distribution of scores on the Mental Health Inventory-5, and intensity of pain. Test for significant difference from the category of no early-life adversity:

*p*\<0.001,

*p*\<0.01,

*p*\<0.05.

**Abbreviations:** CI, confidence interval; OR, odds ratio.

###### 

ORs and 95%CIs for multiple somatic symptoms among chronic pain sufferers with early-life adversity versus no early-life adversity

                                             Early-life adversity (−)   Early-life adversity (+)
  ------------------------------------------ -------------------------- -------------------------------------------------------------------
                                                                        
  **Men**                                                               
  Number of chronic pain sufferers           687                        130
  Number of multiple somatic symptoms (≥3)   283                        59
  Age-adjusted OR (95% CI)                   1.00                       1.57 (1.06--2.34)[\*\*\*](#tfn18-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)         1.00                       1.27 (0.83--1.94)
  **Women**                                                             
  Number of chronic pain sufferers           742                        170
  Number of multiple somatic symptoms (≥3)   379                        117
  Age-adjusted OR (95% CI)                   1.00                       2.10 (1.46--3.00)[\*](#tfn16-jpr-10-427){ref-type="table-fn"}
  Multivariable-adjusted OR (95% CI)         1.00                       1.89 (1.27--2.83)[\*\*](#tfn17-jpr-10-427){ref-type="table-fn"}

**Notes:** Adjusted for age, smoking status, exercise routine, sleep time, body mass index, household expenditure, the full distribution of scores on the Mental Health Inventory-5, and intensity of pain. Test for significant difference from the category of no early-life adversity:

*p*\<0.001,

*p*\<0.01,

*p*\<0.05.

**Abbreviations:** CI, confidence interval; OR, odds ratio.
